289 related articles for article (PubMed ID: 35996506)
1.
Abdelsattar S; Kasemy ZA; Ewida SF; Abo-Elsoud RAA; Zytoon AA; Abdelaal GA; Abdelgawad AS; Khalil FO; Kamel HFM
Br J Biomed Sci; 2022; 79():10238. PubMed ID: 35996506
[No Abstract] [Full Text] [Related]
2. Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt.
Elnagdy MH; Magdy A; Eldars W; Elgamal M; El-Nagdy AH; Salem O; Elmowafy MM; Elborsh OA; Elshafey AW; Kesba MM; Abdulgalil AE; Sobh A
Virol J; 2024 Jan; 21(1):27. PubMed ID: 38263160
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis.
Saengsiwaritt W; Jittikoon J; Chaikledkaew U; Udomsinprasert W
Rev Med Virol; 2022 Jul; 32(4):e2323. PubMed ID: 34997794
[TBL] [Abstract][Full Text] [Related]
4. Genetic Association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) Polymorphisms with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors.
Fernández-de-Las-Peñas C; Arendt-Nielsen L; Díaz-Gil G; Gómez-Esquer F; Gil-Crujera A; Gómez-Sánchez SM; Ambite-Quesada S; Palomar-Gallego MA; Pellicer-Valero OJ; Giordano R
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360172
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population.
Kaidashev I; Izmailova O; Shlykova O; Kabaliei A; Vatsenko A; Ivashchenko D; Dudchenko M; Volianskyi A; Zelinskyy G; Koval T; Dittmer U
Acta Biomed; 2023 Feb; 94(1):e2023030. PubMed ID: 36786264
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
[TBL] [Abstract][Full Text] [Related]
7. Association of ACE2 and TMPRSS2 genes variants with disease severity and most important biomarkers in COVID-19 patients in Bosnia and Herzegovina.
Meseldžić N; Prnjavorac B; Dujić T; Malenica M; Glamočlija U; Prnjavorac L; Bedak O; Imamović Kadrić S; Marjanović D; Bego T
Croat Med J; 2024 Jun; 65(3):220-231. PubMed ID: 38868968
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFα genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
Pecoraro V; Cuccorese M; Trenti T
Clin Exp Med; 2023 Nov; 23(7):3251-3264. PubMed ID: 37055652
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the clinical course of SARS-CoV-2 infections and ACE2 and TMPRSS2 expression and polymorphisms.
Tug E; Fidan I; Bozdayi G; Yildirim F; Tunccan OG; Lale Z; Akdogan D
Adv Clin Exp Med; 2024 Jan; 33(1):39-51. PubMed ID: 37326579
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
[TBL] [Abstract][Full Text] [Related]
11. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease.
Alimoradi N; Sharqi M; Firouzabadi D; Sadeghi MM; Moezzi MI; Firouzabadi N
Virol J; 2022 Mar; 19(1):48. PubMed ID: 35305693
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
13. A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity.
Akin S; Schriek P; van Nieuwkoop C; Neuman RI; Meynaar I; van Helden EJ; Bouazzaoui HE; Baak R; Veuger M; Mairuhu RATA; van den Berg L; van Driel V; Visser LE; de Jonge E; Garrelds IM; Duynstee JFAB; van Rooden JK; Ludikhuize J; Verdonk K; Caliskan K; Jansen T; van Schaik RHN; Danser AHJ
J Hypertens; 2022 Mar; 40(3):606-614. PubMed ID: 34862332
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS-CoV-2 from 946 whole-exome sequencing data in the Turkish population.
Duman N; Tuncel G; Bisgin A; Bozdogan ST; Sag SO; Gul S; Kiraz A; Balta B; Erdogan M; Uyanik B; Canbek S; Ata P; Geckinli BB; Arslan Ates E; Alavanda C; Yesim Ozdemir S; Sezer O; Ozgon GO; Gurkan H; Guler K; Boga I; Kaya N; Alemdar A; Sayan M; Dundar M; Ergoren MC; Temel SG
J Med Virol; 2022 Nov; 94(11):5225-5243. PubMed ID: 35811452
[TBL] [Abstract][Full Text] [Related]
15. Association of TMPRSS2 Gene Polymorphisms with COVID-19 Severity and Mortality: a Case-Control Study with Computational Analyses.
Rokni M; Heidari Nia M; Sarhadi M; Mirinejad S; Sargazi S; Moudi M; Saravani R; Rahdar S; Kargar M
Appl Biochem Biotechnol; 2022 Aug; 194(8):3507-3526. PubMed ID: 35386063
[TBL] [Abstract][Full Text] [Related]
16. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
17. Co-Expression and Localization of Angiotensin-Converting Enzyme-2 (ACE2) and the Transmembrane Serine Protease 2 (TMPRSS2) in Paranasal Ciliated Epithelium of Patients with Chronic Rhinosinusitis.
Kawasumi T; Takeno S; Ishino T; Ueda T; Hamamoto T; Takemoto K; Horibe Y; Takashi O
Am J Rhinol Allergy; 2022 May; 36(3):313-322. PubMed ID: 34989246
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID-19 severity in Iranian population.
Khalilzadeh F; Sakhaee F; Sotoodehnejadnematalahi F; Zamani MS; Ahmadi I; Anvari E; Fateh A
Int J Immunogenet; 2022 Oct; 49(5):325-332. PubMed ID: 36029284
[TBL] [Abstract][Full Text] [Related]
19. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease.
Singh H; Choudhari R; Nema V; Khan AA
Microb Pathog; 2021 Jan; 150():104621. PubMed ID: 33278516
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.
Sabater Molina M; Nicolás Rocamora E; Bendicho AI; Vázquez EG; Zorio E; Rodriguez FD; Gil Ortuño C; Rodríguez AI; Sánchez-López AJ; Jara Rubio R; Moreno-Docón A; Marcos PJ; García Pavía P; Villa RB; Gimeno Blanes JR
PLoS One; 2022; 17(2):e0263140. PubMed ID: 35120165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
